About us





Dato 'Prof. Dr. Hassan Yaacob
is a medical researcher from the University of Malaya.He is the founder of the brand Healin ™ and Healwell Pharmaceuticals Inc.. He is a holder of a doctoral degree (PhD) in the field of Clinical Pharmacology, Royal of Surgeons of England, London. He began seriously Gamat research in the Department of Pharmacology, Faculty of Medicine in 1990.
Research on extended sea cucumber miracle of Kyushu University and the University of Toyamma Japan in 1995-1996 and continued until now. During the research and development of the game, he was awarded the Gold Medal MINDEX (Malaysian Invention and Discovery) in 1994 and Hitachi Science Fellowship Research Award 1995 in Japan. After more than 10 years of research and development game, he managed to produce commercial products based on sea cucumber under the name Healin ™
Company Profile
Eastern Biotech Resources Sdn Bhd (EBRSB) group commenced business in 1996 after years of scientific research conducted on marine organism involving thousand of experiments and studies on Asian and non-Asian subjects.
This research was led by YBhg Professor Dato Dr Hassan Yaacob, who is an academician, a scientist and an entrepreneur. The initial research was conducted in the Department of Pharmacology, Faculty of Medicine, University of Malaya. The research team pursued research and development at Universities in Toyama & Fukuoka Japan from 1995 to 1996.
EBR a leader in the global Marine - Based - Beauty and Healthcare Market, is committed to researching, developing, manufacturing premium quality skin cares and cosmetic products based on biotechnological research.
We emphasize on health supplements based on purified Extract GAMODULIN ® and Advance Skin Care Technology (AG2000).
EBRSB is poised to become the leading Franchiser to market the biotechnology marine based products under brand name HEALIN & AG2000 in Malaysia through its wide distribution networks known as the HOUSE OF HEALIN, a marketing platform in creating awareness for our products.

No comments:

Post a Comment